ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical genetic and genomic testing, today announced enhancements to their portfolio of tests for the detection of genetic mutations ...
Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease Ambry Genetics first implemented RNA testing in 2016 as part of a research and ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics (Ambry), a leader in clinical diagnostic testing, and Tempus, a leader in artificial intelligence and precision medicine, announced today that they ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
ALISO VIEJO, Calif., Oct. 23, 2019 /PRNewswire/ -- Ambry Genetics ® (Ambry), a leading clinical genetics company, announced today the publication in JAMA Network Open of a study on retrospective RNA ...
A genetics testing lab has agreed to pay a $700,000 HIPAA settlement and improve its security practices in the wake of a 2020 phishing hack that affected 225,370 ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), today announced that its CARE Program ...
Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), announced peer-reviewed research demonstrating the potential for variant-specific ...
Law360 (September 12, 2022, 6:05 PM EDT) -- Genetics testing company Ambry Genetics has agreed to pay $12.25 million to settle claims it failed to safeguard customers' medical and personal information ...
Ambry Genetics’ HQ in Aliso Viejo has about 270 of its 1,000 companywide employees New research suggests that Ambry Genetics’ RNA analysis can improve the accuracy of exome testing. The study, ...
ALISO VIEJO, Calif., February 02, 2026--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), announced the ...
Researchers reviewed nearly 2,000 unique genetic variants identified through exome sequencing over a five-year period. About one in ten of these variants were suspected to affect how genes are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results